High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.

Irene PredilettoSarah A FaragUlrike BacherBarbara JekerBehrouz Mansouri TaleghaniRachel BrégyThilo ZanderDaniel BetticherThomas EggerUrban NovakThomas Pabst

Published in: Bone marrow transplantation (2019)

Keyphrases

high dose
newly diagnosed
end stage renal disease
ejection fraction
peritoneal dialysis
prognostic factors
oxidative stress
risk factors
squamous cell carcinoma
patient reported outcomes
radiation therapy